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If you had to have a stroke, where in Europe would
you choose to suffer it? This is the central question in
this book on the assessment of stroke services, raised
in the final evaluating chapter. Stroke is one of the
leading causes of death in contemporary European
countries, and often leaves its survivors disabled and
dependent on professional and family rehabilitation
services and care. Both its incidence and case-fatality
have decreased dramatically in the past decades, but
evidence from different sources suggests that a pla-
teau phase has been reached. Some authors have
argued that the prevalence of stroke has increased
dramatically in the elderly, because increased survival
enables stroke to repeat itself frequently in the same
patient. Further, sharp decreases in stroke incidence
or mortality are not very likely to occur and at this cur-
rent stage, it is appropriate to evaluate the role of
health services in shaping epidemiological trends and
heterogeneity across European countries. In order to
identify possible causes of change in the epidemiology
of stroke and to isolate health services within a causal
complex affecting population outcomes (including risk
factors, stroke severity and stroke management),
measurement is the central theme. Measurement in-
volves topics such as mortality certification and cod-
ing, aspects of stroke severity and case-mix, and
cost-effectiveness. Each of the nine chapters of this
book focuses on portions of this central topic of meas-
urement. Most of the authors are associated with the
European Union-funded BIOMED programme, and the
book’s empirical material is hence derived for a sub-
stantive part from the BIOMED I and BIOMED II cen-
tres. As such, the book is also concerned with the
evaluation of what BIOMED has achieved until now
and what is still left for further exploration.
Chapter 1 is concerned with the problem of interpret-
ing variations in morbidity and mortality. Based on a
review of data (mostly from the WHO-MONICA pro-
ject) the authors argue that the decline in stroke mor-
tality reflects an improvement in stroke case-fatality
rates rather than a decline in the incidence of stroke.
Hypertension treatment, metabolic control of diabetes
and antithrombotic therapy may have reduced the inci-
dence of stroke but may also have reduced its severity
when it occurs. Chapter 2 is about building workable
data sets for health services research and offers an
overview of domains for questions in BIOMED II.
These domains are on patient identification and
demography, pre-stroke measurements, time and date
of onset, use of resources, stroke severity, discharge
destination and functional status at discharge and 3-
month follow-up. Chapter 3 is about population dis-
ease registers and provides twelve characteristics of
a good register. Among the obvious characteristics are
quality procedures aimed at completeness, validation
and timeliness, clear case definition and active case-
ascertainment systems. It is important, but also slightly
worrying that the authors add as a further recommen-
dation that ‘‘the register staff should be equally enthu-
siastic and committed to their work, which requires
incentives such as the writing of reports and publica-
tion of papers’’. Chapter 4 contains a description of
variations in the organisation of care using data of the
participating BIOMED II centres. Chapter 5 attempts
to disentangle the variation in outcomes into differenc-
es in the case mix of stroke admissions and differenc-
es in the ways in which care is delivered. It provides
some evidence for some interventions to have an
impact on outcomes among stroke patients. Chapter
6 is on ‘‘institutional performance’’, using league tables
to rank the BIOMED centres with regard to their mor-
tality and morbidity outcomes. Methods to adjust for
case mix are proposed and applied. Chapter 7 focuses
on the subjective outcome assessment from the
patient’s perspective. It describes the variation in sub-
jective outcomes after stroke across Europe and
attempts to understand it. Chapter 8 describes meth-
odologies (and their pitfalls) to estimate the cost-
effectiveness of stroke care and applies these to the
BIOMED stroke programme. Chapter 9 evaluates the
positive outcomes of European research and identifies
issues that could be tackled in the future.
In our evaluation, we aim to consider what the book
has to offer and to whom, what is missing or dis-
appointing, whether the book is well-organised and
whether the approaches and methods proposed are
amenable to further improvement.
To begin with the merits of the book, we think that it
has much to offer when it comes to the introduction of
the subject, the description of BIOMED activities and
the description of a whole array of problems involvedInternational Journal of Integrated Care – Vol. 3, 4 February 2003 – ISSN 1568-4156 – http://www.ijic.org/
2
in conceptualisation and measurement. Throughout its
chapters the book offers several key methods,
literature and insights that are of value to researchers
in the field of health services research. Most chapters
are quite meticulous in their efforts to describe the
methods used and their many drawbacks. In a certain
way, the overall approach is integrative, as it includes
many aspects of stroke services in terms of structure,
process and outcome. It does not focus on institutional
care only, but also attempts to include rehabilitation
therapies, family roles, and community services as
part of an overall context that may benefit stroke
patients. The evaluation of outcomes moreover is not
only restricted to mere survival, but also involves
health status measurements (mostly using the Barthel
Index) at discharge and by 3 months post stroke.
The book does a good job in describing the complexity
of quantifying the quality of health care and its role
in enhancing probabilities of good outcomes for the
patients involved. It seems, however, that in every
chapter a struggle is taking place to portray this com-
plexity and to stress that questions like ‘‘whether
health services are beneficial in improving stroke
outcomes’’ or ‘‘why there is variation in subjective out-
comes’’ remain unanswered. Even with a well-funded
and large-scale project it thus appears to be difficult
or even impossible to answer the basic questions on
the role of health services in the changing epidemiol-
ogy of stroke. We suggest that the reason so many
questions are left unanswered is because the book
lacks a sound theoretical perspective. The authors
seem so eager to display their measurement skills
they forget to recognise that with the observational
data used some questions can be answered but oth-
ers remain matters of dispute, argumentation or even
confusion. With the inclusion of a review, or meta-anal-
ysis, of trial-investigations, we would have had a better
view on the efficacy of particular stroke health services
to start with. The final chapter on ‘‘Lessons learned’’
contains some of these conceptual notions and could
have been placed at the beginning. The last figure of
the book for instance provides an excellent insight into
the discrepancy between measures of efficacy and
community effectiveness. In this figure, the 25% rela-
tive risk reduction in bad outcomes established in a
meta-analysis of stroke unit trials turns into a com-
munity effectiveness of 7% relative risk reduction, after
variables like incomplete population coverage and
patient adherence have been taken into account. In
the absence of new and integral trial research, we sim-
ply have to work with data that are generated by this
interplay of patient behaviour, disease progression
and stroke epidemiology, health care structures and
physician’s decision-making.
Are the authors successful in dealing with these obser-
vational data sources? Although most methods (such
as those proposed to adjust for case-mix) seem to
work well, we missed a certain feeling for the time-
bound nature of the data and the opportunities to com-
pare cohorts with regard to their different outcomes
using multivariate logistic regression models or surviv-
al analysis. The reason for our discomfort lies partly in
a table presented in Chapter 8. In this table, the costs
of treating male patients are presented by participating
BIOMED centre and separately for survivors and
patients who died in hospital. Some centres are found
to spend more money on their survivors whereas in
other centres the money is allocated to the patients
who died. This table clearly raises many questions
about case-fatality, the duration of the terminal stage,
the balance between lethal and non-lethal outcomes,
and the choices made between life and death.
Throughout the book we increasingly felt that we lost
our touch with the array of patient experiences and
physician responses in time that generate the data
being studied in the book, much in line with Porter’s
phrase:
Patients have roles assigned to them within the scripts
of the modern medical drama. Depending upon who is
doing the analysis or the accountancy, patients appear
as demand, costs and benefits, input or output, voters,
clients or consumers of services, bearers of rights or
pursuers of litigation, diseased bodies or clinical mate-
rial, points on a graph or numbers crunched on a soft-
ware program w2x
Our overall conclusions are that, as far as measure-
ment and description are concerned, there is not much
wrong with the book, thereby justifying conclusions
drawn in the last chapter that ‘‘data collection is fea-
sible’’ and that ‘‘collaboration is stimulating’’. But it
does not, unfortunately, enhance our understanding of
the role health services play in the lives of so many
stroke patients, whether that role is beneficial, dam-
aging or largely indifferent. The book is not very spe-
cific about the particular services that can be offered
during the different stages of stroke and their appraisal
and outcomes w3x, nor does it offer a clear patient-
centric view on integrated care w1x. We know with this
book that there are many places to go to if we had to
have a stroke, but not which centre has the best per-
formance to serve our needs and why that would be
so.
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